The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease

2022 | journal article; research paper. A publication with affiliation to the University of Göttingen.

Jump to:Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease​
Garg, P.; Maass, F.; Sundaram, S. M.; Mollenhauer, B.; Mahajani, S.; van Riesen, C. & Kügler, S. et al.​ (2022) 
Molecular and Cellular Neuroscience121 art. 103746​.​ DOI: https://doi.org/10.1016/j.mcn.2022.103746 

Documents & Media

License

Usage license

Details

Authors
Garg, Pretty; Maass, Fabian; Sundaram, Sivaraj M.; Mollenhauer, Brit; Mahajani, Sameehan; van Riesen, Christoph; Kügler, Sebastian; Bähr, Mathias 
Issue Date
2022
Journal
Molecular and Cellular Neuroscience 
Project
EXC 2067: Multiscale Bioimaging 
Working Group
RG Bähr (Neurobiological Research Laboratory) 
External URL
https://mbexc.uni-goettingen.de/literature/publications/496
ISSN
1044-7431
Language
English

Reference

Citations


Social Media